Table 2.
Averaged standardized uptake value ratios to cerebellum (SUVRCB) from different brain regions of transgenic APP/PS1-21 (TG) and wild-type (WT) mice at different periods after [18F]F-DPA, [18F]DPA-714, and [11C]PBR28 injection
| [18F]F-DPA | [18F]DPA-714 | [11C]PBR28 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TG | WT | TG/WT ratio | TG | WT |
TG/WT ratio |
TG | WT |
TG/WT ratio |
||
| 10–20 min | Brain | 1.05 ± 0.03 | 0.84 ± 0.03 | 1.25 | 0.95 ± 0.02 | 0.92 ± 0.05 | 1.03 *** | 0.97 ± 0.03 | 0.90 ± 0.03 | 1.08 *** |
| Cortex | 1.02 ± 0.05 | 0.70 ± 0.02 | 1.46 | 0.83 ± 0.03 | 0.79 ± 0.04 | 1.05 *** | 0.86 ± 0.04 | 0.77 ± 0.03 | 1.12 *** | |
| Hippocampus | 1.10 ± 0.06 | 0.74 ± 0.04 | 1.49 | 0.96 ± 0.04 | 0.92 ± 0.07 | 1.04 *** # | 1.01 ± 0.04 | 0.89 ± 0.06 | 1.13 *** | |
| Striatum | 1.04 ± 0.05 | 0.67 ± 0.04 | 1.55 | 0.89 ± 0.02 | 0.82 ± 0.06 | 1.09 *** | 0.96 ± 0.05 | 0.82 ± 0.04 | 1.17 *** | |
| Thalamus | 0.97 ± 0.05 | 0.69 ± 0.06 | 1.41 | 0.98 ± 0.03 | 0.92 ± 0.08 | 1.07 *** # | 1.03 ± 0.05 | 0.90 ± 0.07 | 1.14 *** | |
| 20–40 min | Brain | 1.06 ± 0.05 | 0.85 ± 0.04 | 1.25 | 0.95 ± 0.02 | 0.88 ± 0.05 | 1.08 *** | 0.99 ± 0.03 | 0.87 ± 0.03 | 1.14 * |
| Cortex | 1.03 ± 0.05 | 0.71 ± 0.03 | 1.45 | 0.86 ± 0.04 | 0.76 ± 0.04 | 1.13 * | 0.91 ± 0.04 | 0.74 ± 0.03 | 1.23 | |
| Hippocampus | 1.10 ± 0.07 | 0.73 ± 0.06 | 1.51 | 0.97 ± 0.04 | 0.86 ± 0.07 | 1.13*** ## | 1.05 ± 0.05 | 0.83 ± 0.05 | 1.27*** | |
| Striatum | 1.03 ± 0.06 | 0.66 ± 0.05 | 1.56 | 0.91 ± 0.02 | 0.76 ± 0.05 | 1.19 *** | 1.00 ± 0.05 | 0.77 ± 0.04 | 1.30 *** | |
| Thalamus | 0.97 ± 0.05 | 0.66 ± 0.06 | 1.47 | 0.96 ± 0.03 | 0.82 ± 0.07 | 1.17 *** # | 1.02 ± 0.04 | 0.81 ± 0.07 | 1.26 *** | |
| 40–60 min | Brain | 1.07 ± 0.05 | 0.87 ± 0.04 | 1.23 | 0.97 ± 0.02 | 0.86 ± 0.04 | 1.12 * | 1.02 ± 0.03 | 0.86 ± 0.03 | 1.19 |
| Cortex | 1.05 ± 0.05 | 0.74 ± 0.03 | 1.42 | 0.88 ± 0.04 | 0.73 ± 0.04 | 1.21 | 0.96 ± 0.04 | 0.73 ± 0.03 | 1.31 | |
| Hippocampus | 1.09 ± 0.07 | 0.72 ± 0.04 | 1.51 | 0.98 ± 0.04 | 0.81 ± 0.06 | 1.21 *** ## | 1.08 ± 0.04 | 0.79 ± 0.04 | 1.37 * | |
| Striatum | 1.05 ± 0.07 | 0.68 ± 0.06 | 1.54 | 0.91 ± 0.03 | 0.71 ± 0.05 | 1.28 ** | 1.04 ± 0.02 | 0.73 ± 0.04 | 1.42 | |
| Thalamus | 0.97 ± 0.05 | 0.67 ± 0.07 | 1.45 | 0.93 ± 0.03 | 0.74 ± 0.06 | 1.26 ** | 1.03 ± 0.05 | 0.76 ± 0.06 | 1.36 | |
Averaged SUVRCB and standard deviations in whole brain, cortex, hippocampus, striatum, and thalamus of transgenic APP/PS1-21 (TG) and wild-type (WT) mice at different periods after injection (10–20, 20–40, and 40–60 min) using [18F]F-DPA, [18F]DPA-714, and [11C]PBR28 (n = 5–6). * denotes significant differences between [18F]F-DPA SUVRCB TG/WT ratios, and [18F]DPA-714, and [11C]PBR28 SUVRCB TG/WT ratios. # denotes significant differences between [18F]DPA-714 and [11C]PBR28 SUVRCB TG/WT ratios. *p < 0.05, ** p < 0.01, *** p < 0.001, #p < 0.05, ##p < 0.01